182190 people have viewed this drug in the last 60 days
Updated 2025-10-03
| Last Update | 2022-11-04 |
| Register Year | 2016 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | AGALSIDASE ALFA |
| Trade Name | REPLAGAL 1mg/ml concetrate for solution for infusion |
| Strength Unit | mg/ml |
| Pharmaceutical Form | Concentrate for solution for infusion |
| Administration Route | Intravenous use |
| Atc Code1 | A16AB03 |
| Atc Code2 | |
| Size | 3.5 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 1 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $7509.56 |
| Shelf Life | 24 Months |
| Marketing Company | SHIRE HUMAN GENETICS THERAPIES |
| Marketing Country | United States |
| Manufacture Name | Cangene BioPharma Inc. (CBI) |
| Manufacture Country | United States |
| Secondry package manufacture | |
| Main Agent | Salehiya Trading Co. |
| Secosnd Agent | Abdulrehman Algosaibi G.T.C. |
| Third Agent | |
| Visits | 182190 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| REPLAGAL 1mg/ml concetrate for solution | $7509.56 | 182190 visits | 2022-11-04 |